• Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us
Home
  • Providers
    • Hospitals
    • Practices
    • Retail
  • Health Tech
    • AI and Machine Learning
    • Digital Health
    • Telehealth
  • Payers
  • Regulatory
  • Finance
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • DEI Awards
    • Innovation Awards
  • Resources
    • Webinars
    • Fierce Events
    • Industry Events
    • Podcasts
    • Survey
    • Whitepapers
  • Events
  • Subscribe
Home
Subscribe
Hamburger Menu Hamburger Menu
  • Providers
    • Hospitals
    • Practices
    • Retail
  • Health Tech
    • AI and Machine Learning
    • Digital Health
    • Telehealth
  • Payers
  • Regulatory
  • Finance
  • Special Reports
  • Fierce 50
    • Special Report
    • Awards Gala
  • Awards
    • DEI Awards
    • Innovation Awards
  • Resources
    • Webinars
    • Fierce Events
    • Industry Events
    • Podcasts
    • Survey
    • Whitepapers
  • Events
  • Subscribe
  • Fierce Pharma
  • Fierce Biotech
  • Fierce Healthcare
  • Fierce Life Sciences Events
  • Advertise
  • About Us

special purpose acquisition company

Mergers and acquisitions deals consolidation
Providers

Cano Health exploring sale as its cash dwindles, lays off 700

Cano Health is exploring a sale and plans to lay off 700 employees. It also warned that the company may run out of cash in the next 12 months.
Heather Landi Aug 10, 2023 4:46pm
A person holding a smartphone in their hand with screen shot of Babylon Health app

Babylon to go private in deal with AlbaCore Capital Group

Jun 26, 2023 7:30am
Boardroom standoff

Cano Health CEO exits as company aims to turn around business

Jun 16, 2023 5:00pm
money and shares declining

Cano Health separates chairman, CEO roles amid board shakeup

Apr 17, 2023 10:30am
San Francisco storm

JPM23's Health Tech Tidbits: Talkspace's path to profitability

Jan 16, 2023 7:45pm
23andM3 executive ring the Nasdaq opening bell on the day the company goes public

Why data is 23andMe's 'secret power' for drug development

Jan 20, 2022 5:00pm

Home
  • Connect
    • The Team
    • Advertise
    • Marketing Kit
    • Let's Talk
  • Join Us
    • Newsletters
    • Resources
    • RSS Feeds
    • Editorial Advisory Council
  • Our Brands
    • Fierce Pharma
    • Fierce Biotech
    • Fierce Healthcare
  • Our Events
    • Life Sciences Events
©2025 Questex LLC All rights reserved.
Terms of use
Privacy Policy
Privacy Settings